Medicare Prescription Drug, Improvement, and Modernization Act of 2003; Section 1013: Identification of Priority Topics for Effective Health Care Research, 600-601 [06-69]
Download as PDF
<![CDATA[
600
Federal Register / Vol. 71, No. 3 / Thursday, January 5, 2006 / Notices
Peter J. King,
Deputy Director, Bureau of Certification and
Licensing.
[FR Doc. E5–8321 Filed 1–4–06; 8:45 am]
BILLING CODE 6730–01–P
Reason: Failed to maintain a valid bond.
Peter J. King,
Deputy Director, Bureau of Certification and
Licensing.
[FR Doc. E5–8314 Filed 1–4–06; 8:45 am]
BILLING CODE 6730–01–P
Board of Governors of the Federal Reserve
System, December 30, 2005.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E5–8302 Filed 1–4–06; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL MARITIME COMMISSION
FEDERAL RESERVE SYSTEM
cchase on PROD1PC60 with NOTICES
Ocean Transportation Intermediary
License Revocations
The Federal Maritime Commission
hereby gives notice that the following
Ocean Transportation Intermediary
licenses have been revoked pursuant to
section 19 of the Shipping Act of 1984
(46 U.S.C. app. 1718) and the
regulations of the Commission
pertaining to the licensing of Ocean
Transportation Intermediaries, effective
on the corresponding date shown below:
License Number: 004059F.
Name: Pacific Multi-Modal, Inc.
Address: 840 West 12th Street, Long
Beach, CA 90813.
Date Revoked: November 30, 2005.
Reason: Failed to maintain a valid bond.
License Number: 018249F.
Name: JJB Trucking Services Corp. &
Shipping.
Address: 333 N. Broad Street, Elizabeth,
NJ 07200.
Date Revoked: December 2, 2005.
Reason: Failed to maintain a valid bond.
License Number: 003722F.
Name: Falcon Transportation &
Forwarding Corp.
Address: 500 Bi-County Boulevard,
Suite 213N, Farmingdale, NY 11735.
Date Revoked: November 20, 2005.
Reason: Failed to maintain a valid bond.
License Number: 018793NF.
Name: Berr International, Inc.
Address: 8344 NW 30 Terrace, Miami,
FL 33122.
Date Revoked: December 17, 2005.
Reason: Failed to maintain a valid bond.
License Number: 001227F.
Name: Fast Shipping Co.
Address: P.O. Box 523363, Miami, FL
33152.
Date Revoked: November 23, 2005.
Reason: Surrendered license
voluntarily.
License Number: 015593NF.
Name: Cross Trans Service USA, Inc.
Address: 1480 Elmhurst Road, Elk
Grove, IL 60007.
Date Revoked: December 18, 2005.
Reason: Failed to maintain a valid bond.
License Number: 016626NF.
Name: Touchstone Shipping &
Logistics, Inc. dba JBS Transport Line.
Address: 17350 SH 249, Suite 320,
Houston, TX 77064.
Date Revoked: November 25, 2005.
VerDate Aug<31>2005
17:06 Jan 04, 2006
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Agency for Healthcare Research and
Quality
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
Web site at https://www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than January 31,
2005.
Medicare Prescription Drug,
Improvement, and Modernization Act
of 2003; Section 1013: Identification of
Priority Topics for Effective Health
Care Research
A. Federal Reserve Bank of Atlanta
(Andre Anderson, Vice President) 1000
Peachtree Street, NE., Atlanta, Georgia
30303:
1. Whitney Holding Corporation, New
Orleans, Louisiana, to merge with First
National Bancshares, Inc., and thereby
indirectly acquire 1st National Bank and
Trust, both of Bradenton, Florida.
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of invitation to submit
research recommendations.
AGENCY:
SUMMARY: The U.S. Department of
Health and Human Services invites
suggestions from interested
organizations and knowledgeable
individuals regarding the highest
priorities for research, demonstration,
and evaluation projects to support and
improve the Medicare, Medicaid, and
State Children Health Insurance (SCHIP)
programs.
The research and other activities
undertaken and authorized by the
above-captioned or above referenced
statutory provision may address:
1. The outcomes, comparative clinical
effectiveness, and appropriateness of
health care items and services
(including prescription drugs); and
2. Strategies for improving the
efficiency and effectiveness of such
programs, including the ways in which
such items and services are organized,
managed, and delivered under such
programs.
The statute:
a. Requires the establishment of a
priority setting process for identifying
the most important topics to address,
b. Establishes a timetable for
development of an initial priority list
and completion of the research; and
c. Requires ongoing consultation with
relevant stakeholders.
To review the text of section 1013 of
the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, please visit Section 1013.
Research on Outcomes of Health Care
Items and Services (PDF 21.7 KB) or
https://www.medicare.gov/
medicarereform/108s1013.htm (text).
Current priority conditions being
studied focus on topics particularly
relevant to Medicare beneficiaries. The
E:\FR\FM\05JAN1.SGM
05JAN1
Federal Register / Vol. 71, No. 3 / Thursday, January 5, 2006 / Notices
next set of priority conditions will be
expanded to include conditions relevant
to the Medicaid and SCHIP programs.
The current priority conditions are:
• Arthritis and non-traumatic joint
disorders.
• Cancer.
• Chronic obstructive pulmonary
disease and asthma.
• Dementia including Alzheimer’s
disease.
• Depression and other mood
disorders.
• Diabetes mellitus.
• Ischemic heart disease.
• Peptic ulcer disease and dyspepsia.
• Pneumonia.
• Stroke and hypertension.
DATES: Research recommendations for
the next priority conditions list must be
received by March 1, 2006.
ADDRESSES: Recommendations for
consideration and possible inclusion in
the next priority list may be submitted
electronically to the Effective Health
Care Program Web site, https://
www.EffectiveHealthCare.ahrq.gov, or emailed to
EffectiveHealthCare@ahrq.gov.
Recommendations may also be mailed
to: AHRQ Effective Health Care Program
c/o Center for Outcomes and Evidence,
Agency for Healthcare Research and
Quality, 540 Gaither Road, Rockville,
MD 20850.
All comments will be posted in an
electronic reading room at: https://
www.EffectiveHealthCare.ahrq.gov.
FOR FURTHER INFORMATION CONTACT:
Effective Health Care Program at (301)
427–1502 or Effective
HealthCare@ahrq.gov.
More information about the Effective
Health Care Program is available at
https://
www.EffectiveHealthCare.ahrq.gov.
If issues arise for which the expertise
of other components of the U.S.
Department of Health and Human
Services or other Federal departments
would be helpful in prioritizing
suggested research topics,
representatives from those entities will
be added to, or consulted by the
Steering Committee as warranted.
Steering Committee staff will prepare
a preliminary ranking of suggested
topics for study taking into
consideration factors suggested by the
terms of Section 1013(a)(2)(C): Health
care items or services that impose high
costs on Medicare, Medicaid, or SCHIP
programs; those which may be
underutilized or overutilized; and those
which may significantly improve the
prevention, treatment, or cure of
diseases and conditions which impose
high direct or indirect costs on patients
or society.
Stakeholder Consultation
The statute requires a broad, ongoing
process of consultation with relevant
stakeholders. Because two of the
programs addressed by the statute are
administered by the States, the
Department will work with the States to
develop an effective process for
identifying their priority
recommendations for research.
To meet the requirement for ongoing
consultation with other stakeholders,
the Department will issue a specific
solicitation for research
recommendations every year and will
permit stakeholders to submit research
recommendations throughout the year.
Dated: December 28, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 06–69 Filed 1–4–06; 8:45 am]
BILLING CODE 4160–90–M
cchase on PROD1PC60 with NOTICES
SUPPLEMENTARY INFORMATION:
Recommendations for research that are
made by the Centers for Medicare &
Medicaid Services (CMS), the States,
and other stakeholders will be reviewed
and prioritized by a steering committee
composed of representatives from the
following components of the U.S.
Department of Health and Human
Services:
• Office of the Secretary.
• Assistant Secretary for Planning
and Evaluation (ASPE).
• Assistant Secretary for Budget,
Technology, and Finance (ASBTF).
• Centers for Medicare & Medicaid
Services (CMS).
• Food and Drug Administration
(FDA).
• Agency for Healthcare Research and
Quality (AHRQ, the agency designated
by the statute to carry out the research).
VerDate Aug<31>2005
17:06 Jan 04, 2006
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 70 FR 72842–72843,
dated December 7, 2005) is amended to
reflect the reorganization of the Office of
Health and Safety, within the Office of
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
601
the Director, Centers for Disease Control
and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the titles and
functional statements for the Office of
Health and Safety (CA1).
After the mission statement for the
Management Information Systems
Office (CAJN), Office of the Chief
Operating Officer (CAJ), insert the
following:
Office of Health and Safety (CAJP).
The key responsibility of the Office of
Health and Safety (OHS) of the Centers
for Disease Control and Prevention
(CDC) is to protect the welfare of
workers as they carry out their public
health mission. By creating a safe,
healthful workplace environment, by
preventing work-related injury and
illness, and by promoting safe work
practices, the office improves worker
morale, increases efficiency and
contributes to the creation of sound
public health science. OHS also serves
as a significant resource of subject
matter expertise for the national and
international community in the field of
biosafety, and works with key partners,
such as the World Health Organization
and others, on critical health and safety
issues around the globe.
More specifically, the OHS: (1)
Provides leadership and service for the
CDC Health and Safety Program (HSP)
to proactively ensure safe and healthy
workplaces at CDC worksites for CDC
employees, contractors, and visitors
(including deployed personnel), and to
protect the environment and
communities adjacent to CDC-owned
and leased facilities; (2) promotes
healthy and safe work practices to
prevent injury and illness, and provides
occupational medical, employee
assistance, and worksite health
promotion/lifestyle services; (3)
provides advice and counsel to the CDC
Director and other senior OD and
national centers’ staff on health, safety,
and environment-related matters, and to
individuals and organizations nationally
and internationally, as requested; (4)
provides advice, counsel, and direct
support services to supervisors and
employees on health, safety, and
environment-related matters; (5) assures
compliance with applicable federal,
state, and local health, safety, and
environmental (HSE) laws and
regulations; (6) provides liaison with
both CDC safety officers and staff, and
other partners such as Health and
Human Services (HHS) health and
safety officials, Occupational Safety and
Health Administration (OSHA),
Environmental Protection Agency
E:\FR\FM\05JAN1.SGM
05JAN1
]]>Agencies
[Federal Register Volume 71, Number 3 (Thursday, January 5, 2006)]
[Notices]
[Pages 600-601]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-69]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Medicare Prescription Drug, Improvement, and Modernization Act of
2003; Section 1013: Identification of Priority Topics for Effective
Health Care Research
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of invitation to submit research recommendations.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services invites
suggestions from interested organizations and knowledgeable individuals
regarding the highest priorities for research, demonstration, and
evaluation projects to support and improve the Medicare, Medicaid, and
State Children Health Insurance (SCHIP) programs.
The research and other activities undertaken and authorized by the
above-captioned or above referenced statutory provision may address:
1. The outcomes, comparative clinical effectiveness, and
appropriateness of health care items and services (including
prescription drugs); and
2. Strategies for improving the efficiency and effectiveness of
such programs, including the ways in which such items and services are
organized, managed, and delivered under such programs.
The statute:
a. Requires the establishment of a priority setting process for
identifying the most important topics to address,
b. Establishes a timetable for development of an initial priority
list and completion of the research; and
c. Requires ongoing consultation with relevant stakeholders.
To review the text of section 1013 of the Medicare Prescription
Drug, Improvement, and Modernization Act of 2003, please visit Section
1013. Research on Outcomes of Health Care Items and Services (PDF 21.7
KB) or https://www.medicare.gov/medicarereform/108s1013.htm (text).
Current priority conditions being studied focus on topics
particularly relevant to Medicare beneficiaries. The
[[Page 601]]
next set of priority conditions will be expanded to include conditions
relevant to the Medicaid and SCHIP programs.
The current priority conditions are:
Arthritis and non-traumatic joint disorders.
Cancer.
Chronic obstructive pulmonary disease and asthma.
Dementia including Alzheimer's disease.
Depression and other mood disorders.
Diabetes mellitus.
Ischemic heart disease.
Peptic ulcer disease and dyspepsia.
Pneumonia.
Stroke and hypertension.
DATES: Research recommendations for the next priority conditions list
must be received by March 1, 2006.
ADDRESSES: Recommendations for consideration and possible inclusion in
the next priority list may be submitted electronically to the Effective
Health Care Program Web site, https://www.EffectiveHealthCare.ahrq.gov,
or e-mailed to EffectiveHealthCare@ahrq.gov.
Recommendations may also be mailed to: AHRQ Effective Health Care
Program c/o Center for Outcomes and Evidence, Agency for Healthcare
Research and Quality, 540 Gaither Road, Rockville, MD 20850.
All comments will be posted in an electronic reading room at:
https://www.EffectiveHealthCare.ahrq.gov.
FOR FURTHER INFORMATION CONTACT: Effective Health Care Program at (301)
427-1502 or Effective HealthCare@ahrq.gov.
More information about the Effective Health Care Program is
available at https://www.EffectiveHealthCare.ahrq.gov.
SUPPLEMENTARY INFORMATION: Recommendations for research that are made
by the Centers for Medicare & Medicaid Services (CMS), the States, and
other stakeholders will be reviewed and prioritized by a steering
committee composed of representatives from the following components of
the U.S. Department of Health and Human Services:
Office of the Secretary.
Assistant Secretary for Planning and Evaluation (ASPE).
Assistant Secretary for Budget, Technology, and Finance
(ASBTF).
Centers for Medicare & Medicaid Services (CMS).
Food and Drug Administration (FDA).
Agency for Healthcare Research and Quality (AHRQ, the
agency designated by the statute to carry out the research).
If issues arise for which the expertise of other components of the
U.S. Department of Health and Human Services or other Federal
departments would be helpful in prioritizing suggested research topics,
representatives from those entities will be added to, or consulted by
the Steering Committee as warranted.
Steering Committee staff will prepare a preliminary ranking of
suggested topics for study taking into consideration factors suggested
by the terms of Section 1013(a)(2)(C): Health care items or services
that impose high costs on Medicare, Medicaid, or SCHIP programs; those
which may be underutilized or overutilized; and those which may
significantly improve the prevention, treatment, or cure of diseases
and conditions which impose high direct or indirect costs on patients
or society.
Stakeholder Consultation
The statute requires a broad, ongoing process of consultation with
relevant stakeholders. Because two of the programs addressed by the
statute are administered by the States, the Department will work with
the States to develop an effective process for identifying their
priority recommendations for research.
To meet the requirement for ongoing consultation with other
stakeholders, the Department will issue a specific solicitation for
research recommendations every year and will permit stakeholders to
submit research recommendations throughout the year.
Dated: December 28, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 06-69 Filed 1-4-06; 8:45 am]
BILLING CODE 4160-90-M
